Purple Biotech (PPBT) Current Assets (2017 - 2021)

Purple Biotech (PPBT) has disclosed Current Assets for 4 consecutive years, with $48.5 million as the latest value for Q4 2021.

  • On a quarterly basis, Current Assets fell 18.23% to $48.5 million in Q4 2021 year-over-year; TTM through Dec 2021 was $48.5 million, a 18.23% decrease, with the full-year FY2021 number at $48.5 million, down 18.23% from a year prior.
  • Current Assets was $48.5 million for Q4 2021 at Purple Biotech, down from $59.3 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $59.3 million in Q4 2020 to a low of $8.3 million in Q4 2019.
  • A 4-year average of $31.1 million and a median of $28.5 million in 2018 define the central range for Current Assets.
  • Peak YoY movement for Current Assets: surged 614.07% in 2020, then dropped 18.23% in 2021.
  • Purple Biotech's Current Assets stood at $8.5 million in 2018, then decreased by 2.49% to $8.3 million in 2019, then soared by 614.07% to $59.3 million in 2020, then fell by 18.23% to $48.5 million in 2021.
  • Per Business Quant, the three most recent readings for PPBT's Current Assets are $48.5 million (Q4 2021), $59.3 million (Q4 2020), and $8.3 million (Q4 2019).